International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA

Yiu-Lian is the Innovation Lead for Diagnostics, at Johnson & Johnson Innovation, London. Prior to joining Johnson & Johnson Innovation, Yiu-Lian was Divisional Vice President for R&D at Abbott Molecular. In this position, she was responsible for R&D strategic oversight, menu expansion, and the development of next generation molecular diagnostic platform technologies. Previously, she was the Executive Director of Molecular Diagnostics and Companion Diagnostics Development at Novartis Oncology. Yiu-Lian brings a broad and extensive background in the pharmaceutical and biotechnology industries including experience in technology and product development, blood testing/screening, vaccines and IVD Immuno and molecular diagnostics, as well as therapeutic drug/vaccine development.

•Develop and/or execute business strategies for genetics, oncology, infectious disease, metabolic disease, and neuroscience •Develop and drive technical strategies for drug and companion diagnostics co-development • Recruit and develop talents, build functional departments and project teams, develop and implement product development and project management tools and processes, grow organization. • Direct, manage and oversee R&D functions for biological drug and vaccine development, blood screening, and IVD product development: Biomarker Development, Assay Development, System and SW Engineering, System Integration, Design Transfer, Technology Transfer, Technology Development, Process Development and Validation, Pilot Production, Analytical Method Development and Method Validation, QC Testing, Project Management (PMO) and Scientific Affairs. •Drug development CMC lead or core team member: Phase I, II and III IND, and NDA/BLA submissions for biological and blood screening. •Technology assessments and strategic alignment for M&A and BDL initiatives •Strategic alliance with partners and vendors, drive and manage collaborations

Dr. Leyla B. Djansugurova is a Full Professor of Genetics, PhD. Current position - General Director of the Institute of General Genetics and Cytology (Almaty, Republic of Kazakhstan). She specialized in cytogenetics, molecular genetics, and cell biology. Training and research experience: Department of genetics, Moscow State University named M.Y. Lomonosov; Institute of molecular genetics RAS, Moscow, Russia; Institute of Gene Biology RAS, Moscow, Russia; Department of genetics, Leicester University, Leicester, Great Britain.

Dr. Leyla B. Djansugurova’s research interests: Drosophila genetics, Human genetics, genetic instability, apoptosis; individual susceptibility and resistance to cancer and hazard environmental influence; cancer genetics, and genetics of ageing. She is an independent expert in the field of DNA fingerprinting. Leyla Djansugurova was an executor of 2 international grants, and 11 Kazakhstan research projects were done under her leadership. In total she has 236 papers, 5 workbooks, 2 monographs, 3 patents. There are 7 PhD research works were done under her supervising, currently 3 PhD students are being prepared. Twice she has been awarded by governmental awards for her contribution to science. Her activities in cancer research were related to oncovirus-induced mutagenesis, elucidation the role of apoptotic key genes in development of cervical and esophageal cancers, the lectin based approach to early detection of cancer cells, the molecular epidemiology of sporadic and inherited forms of cervical, esophageal and colorectal cancers.

Since 1988 Dr. Kuppen is connected with Leiden University Medical Centre. As researcher at the Department of Pathology in 1993 he defended his thesis \\\"Studies on interleukin-2-activated rat natural killer cells. Establishment of a syngeneic model for adoptive immunotherapy of cancer\\\'\\\'. He became researcher and Head of the research group \\\'Immunotherapy of cancer\\\' at the Department of Surgery. In 2001 Dr. Kuppen became head of the Laboratory for Surgical Oncology and in 2009 Head of the Research Laboratory for Surgery. Besides a researcher Dr. Kuppen is coordinator of the program for academic training of the study Biomedical Sciences.

His Research interests as a project leader in research surgical oncology are Immunotherapy colorectal cancer and Diagnostic and prognostic factors for colon and breast cancers. He is an expert on cancer immunotherapy, focused on colorectal cancer and prognostic and predictive biomarkers in colorectal and breast cancer.

Hans Jorgen Nielsen is a Professor, Consultant and Head of Surgical Immunology Laboratory, Dept. of Surgical Gastroenterology, Hvidovre University Hospital, Denmark. He worked as a CEO – Ejner Nielsen Trucking Co. from July 1972 to January 1982, He was a Danish Cancer Society Professor of Surgical Oncology, University of Copenhagen till Nov 2003 and was a Clinical Professor of Surgical Oncology in University of Copenhagen till Nov. 2008.He was a Post. Doc. in University of Copenhagen from June 1996 to December 1997.He was a PI of international multicenter (26 centers) on treatment of Colorectal Cancer, 1991 - 1996 and he is a PI of national multicenter studies on early detection of recurrence of Colorectal Cancer. Author/co-author of > 270 papers. Visiting professor, Rochester, New York. His present position since January 1998 is currently he is a Professor, Consultant, Head of Surgical Immunology Laboratory, Dept. of Surgical Gastroenterology, and Hvidovre University Hospital.

He worked as a Junior Research Scientist in Dept. of Surgical Gastroenterology, Hvidovre University Hospital from July 1987 to June 1989 for 24 months and as s Senior Research Scientist in Dept. of Surgical Gastroenterology, Hvidovre University Hospital from September 1990 to May 1996 for 69 months. His research interests are working with development of a new screening concept for CRC based on blood-based biomarkers (proteomics, genomics, epigenomics, and metabilomics in various combinations).

Suresh Kumar A/L P Govind is a Professor in the Department of Parasitology and the Faculty of Medicine in University of Malaya, Kuala Lumpur, Malaysia.

His research interests are Blastocystis sp. subtype 3 triggers higher proliferation of human colorectal cancer cells, HCT116, Diagnostic Parasitology, Drug Trials and Biology Of Parasites, In Vitro Culture And Ultra Structure Of Protozoans, Parasitology (water borne protozoans -Blastocystis) and Parasitology (Trichomonas vaginlis , Microsporidium).